Home

model Mizerabil solar bcr prognostics table Publicitate povârniș Est

Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid  Leukemia
Frontiers | BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia

BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted  therapy | Haematologica
BCR-ABL1-like acute lymphoblastic leukemia in childhood and targeted therapy | Haematologica

PDF] Chronic Myeloid Leukemia--Prognostic Value of Mutations. | Semantic  Scholar
PDF] Chronic Myeloid Leukemia--Prognostic Value of Mutations. | Semantic Scholar

Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations  in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic  Myeloid Leukemia - Clinical Lymphoma, Myeloma and Leukemia
Comparison of Frequency and Sensitivity of BCR-ABL1 Kinase Domain Mutations in Asian and White Patients With Imatinib-resistant Chronic–Phase Chronic Myeloid Leukemia - Clinical Lymphoma, Myeloma and Leukemia

Frontiers | Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in  Colorectal Cancer
Frontiers | Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped  subsets: analysis within prospective clinical trials of the German CLL  Study Group (GCLLSG) | Haematologica
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG) | Haematologica

Cancers | Free Full-Text | Regulation of B-Cell Receptor Signaling and Its  Therapeutic Relevance in Aggressive B-Cell Lymphomas
Cancers | Free Full-Text | Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas

Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian  Imatinib-Resistant Patients With Chronic Myeloid Leukemia | JCO Global  Oncology
Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia | JCO Global Oncology

Incidence, characteristics and risk factors of thromboembolic events in  East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms |  Scientific Reports
Incidence, characteristics and risk factors of thromboembolic events in East Asian patients with BCR-ABL1 negative myeloproliferative neoplasms | Scientific Reports

Prognostic impact of chromosomal abnormalities and copy number alterations  in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study |  Leukemia
Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study | Leukemia

Treatment schedule for BCR-ABL-positive ALL in the JALSG ALL202 study |  Download Table
Treatment schedule for BCR-ABL-positive ALL in the JALSG ALL202 study | Download Table

Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian  Imatinib-Resistant Patients With Chronic Myeloid Leukemia | JCO Global  Oncology
Spectrum of BCR-ABL Mutations and Treatment Outcomes in Ethiopian Imatinib-Resistant Patients With Chronic Myeloid Leukemia | JCO Global Oncology

Prognostic value of NUCB2 protein expression for the BCR-free survival... |  Download Table
Prognostic value of NUCB2 protein expression for the BCR-free survival... | Download Table

Quantitative measurement of BCR/abl transcripts usingreal-time polymerase  chain reaction - Annals of Oncology
Quantitative measurement of BCR/abl transcripts usingreal-time polymerase chain reaction - Annals of Oncology

Response by baseline BCR-ABL mutation analysis | Download Table
Response by baseline BCR-ABL mutation analysis | Download Table

IKZF1 Deletion Subtyping and Outcome Analysis in BCR–ABL1-Negative  Pediatric B-Cell Acute Lymphoblastic Leukemia: A Single-Institution  Experience from North India - Clinical Lymphoma, Myeloma and Leukemia
IKZF1 Deletion Subtyping and Outcome Analysis in BCR–ABL1-Negative Pediatric B-Cell Acute Lymphoblastic Leukemia: A Single-Institution Experience from North India - Clinical Lymphoma, Myeloma and Leukemia

Prognostic value of NUCB2 protein expression for the BCR-free survival... |  Download Table
Prognostic value of NUCB2 protein expression for the BCR-free survival... | Download Table

Adherence and clinical responses with BCR-ABL1 TKI treatment. 56-62 |  Download Table
Adherence and clinical responses with BCR-ABL1 TKI treatment. 56-62 | Download Table

Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid  Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology

Table 1 from Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of  characteristics, outcomes, and prognostic significance. | Semantic Scholar
Table 1 from Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance. | Semantic Scholar

Prognostic value of GADD45B expression for the BCR- | Download Table
Prognostic value of GADD45B expression for the BCR- | Download Table

Table 3 from Prognostic Implication of BCR-ABL Fusion Transcript Variants  in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its  Kind Study on CML Patients of Kashmir | Semantic Scholar
Table 3 from Prognostic Implication of BCR-ABL Fusion Transcript Variants in Chronic Myeloid Leukemia (CML) Treated with Imatinib. A First of Its Kind Study on CML Patients of Kashmir | Semantic Scholar

The BCR prognostic model possesses the accuracy and robustness.(A)... |  Download Scientific Diagram
The BCR prognostic model possesses the accuracy and robustness.(A)... | Download Scientific Diagram